The state of the immune system in abdominal sepsis


Cite item

Full Text

Abstract

Sepsis is a serious condition characterized by a complex dysfunction of internal organs and systems. In the basis of the pathogenesis of sepsis, the leading role is played by the dysregulation of the immune response to the infectious agent, in particular endotoxin of gramnegative bacteria, which is an obligate lipopolysaccharide of the bacterial wall. Aim. To evaluate the prognostic value of cytokine profile, phagocytosis activity indices, endotoxin concentration and activity in blood in gram-negative sepsis. Materials and methods. 78 patients with abdominal sepsis were included in a one-center prospective cohort study, of them 45 died. All the patients were evaluated for the concentration of circulating cytokines (TNF-α, IFN-γ, IL-6, IL-8, IL-10), cellular molecules (CD3, CD45RO, CD95 and HLA-DR), bactericidal and phagocytic activity of neutrophils and endotoxin (lipopolysaccharide) level in peripheral blood. Results and discussion. The concentrations of all cytokines were slightly lower in the survivors. Significant differences were noted for TNF-α (p=0.001), IL-6 (p=0.001), and IL-8 (p=0.007). The expression of HLA-DR molecules was slightly higher (p=0.055), and CD95 was lower (p=0.146) in survivors than in the dead. However, the differences have not reached the required level of statistical significance. The phagocytic (p<0.001) and bactericidal activity (р=0.002 for stimulated activity and p=0.001 for spontaneous activity) of neutrophils is significantly different. In survived patients, we noted large values of stimulated bactericidal activity and phagocytic index than the dead. Level of spontaneous activity in survivors was lower. In subsequently deceased patients, the level of endotoxin load was higher than in the surviving patients: level of lipopolysaccharide concentration (p=0.002), endotoxin activity (p=0.032) and neutrophils activity (p=0.028). Conclusion. Evaluation of cytokine levels is informative, but due to the high spread of indicators in different patients, should be carried out in the dynamics. The most informative prognostic parameters in sepsis are the concentration and activity of lipopolysaccharides (endotoxin), phagocytic and bactericidal activity of neutrophils. The EAA (endotoxin activity assay) assessment should be conducted in conjunction with the neutrophil "response" assessment.

About the authors

R V Koshelev

M.F. Vladimirskiy Moscow Regional Research and Clinical Institute (MONIKI)

Email: koshelevrv@yandex.ru
к.м.н., зам. гл. врача по консультативно-диагностической работе, доц. курса клинической трансфузиологии при каф. анестезиологии и реанимации факультета усовершенствования врачей Moscow, Russia

A V Vatazin

M.F. Vladimirskiy Moscow Regional Research and Clinical Institute (MONIKI)

д.м.н., проф., руководитель отд. трансплантологии, нефрологии и хирургической гемокоррекции Moscow, Russia

A B Zulkarnayev

M.F. Vladimirskiy Moscow Regional Research and Clinical Institute (MONIKI)

д.м.н., гл.н.с. хирургического отд-ния трансплантологии и диализа Moscow, Russia

A P Faenko

M.F. Vladimirskiy Moscow Regional Research and Clinical Institute (MONIKI)

ассистент курса клинической трансфузиологии при каф. анестезиологии и реаниматологии факультета усовершенствования врачей Moscow, Russia

References

  1. Singer M, Deutschman C, Seymour C, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10. doi: 10.1001/jama.2016.0287
  2. Alexandraki I, Palacio C. Gram - negative versus Gram - positive bacteremia: what is more alarmin(g)? Crit Care. 2010;14(3):161. doi: 10.1186/cc9013
  3. Ani C, Farshidpanah S, Bellinghausen Stewart A, Nguyen H. Variations in organism - specific severe sepsis mortality in the United States: 1999-2008. Crit Care Med. 2015;43(1):65-77. doi: 10.1097/CCM.0000000000000555
  4. Bell J, Turnidge J, Coombs G, et al. Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014. Commun Dis Intell Q Rep. 2016;40(2):229-35.
  5. Ergönül Ö, Aydin M, Azap A, et al. Healthcare - associated Gram - negative bloodstream infections: antibiotic resistance and predictors of mortality. J Hosp Infect. 2016;94(4):381-5. doi: 10.1016/j.jhin.2016.08.012
  6. Ивличев А.В., Чувашова М.С., Ляпина Е.П., Лиско О.Б., Царева Т.Д. Особенности течения сепсиса по данным реанимационного отделения ГУЗ СО «СГКБ №2 им. В.И. Разумовского» г. Саратова. Саратовский научно - медицинский журнал. 2016;12(2):222.
  7. Савина В.А., Колосовская Е.Н., Лебедев В.Ф. Актуальные вопросы эпидемиологии сепсиса. Медицинский альманах. 2014;34(4):20-2.
  8. Opal S.M. Endotoxins and other sepsis triggers. Contrib Nephrol. 2010;167:14-24. doi: 10.1159/000315915
  9. Christodoulou S, Kyriazopoulou E, Chrysanthakopoulou M, et al. Lipid peroxidation in Gram - negative bacteremia modulates the risk for septic shock and infections by resistant Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis. 2017;36(11):2171-7. doi: 10.1007/s10096-017-3041-5
  10. Boisramé-Helms J, Kremer H, Schini-Kerth V, Meziani F. Endothelial dysfunction in sepsis. Curr Vasc Pharmacol. 2013;11(2):150-60.
  11. Brown K.A, Brown G.A, Lewis S.M, Beale R, Treacher D.F. Targeting cytokines as a treatment for patients with sepsis: A lost cause or a strategy still worthy of pursuit? Int Immunopharmacol. 2016;36:291-9. doi: 10.1016/j.intimp.2016.04.041
  12. Chousterman B.G, Swirski F.K, Weber G.F. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39(5):517-28. doi: 10.1007/s00281-017-0639-8
  13. Balk R. , Roger C. , Bone M.D and the evolving paradigms of sepsis. Contrib Microbiol. 2011;17:1-11. doi: 10.1159/000323970
  14. Opal S.M. The evolution of the understanding of sepsis, infection, and the host response: a brief history. Crit Care Nurs Clin North Am. 2011;23(1):1-27. doi: 10.1016/j.ccell.2010.12.001
  15. Rhodes A, Evans L.E, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-77. doi: 10.1007/s00134-017-4683-6
  16. Matsumoto N, Takahashi G, Kojika M, et al. Interleukin-8 induces an elevation in the endotoxin activity assay (EAA) level: does the EAA truly measure the endotoxin level? J Infect Chemother. 2013;19(5):825-32. doi: 10.1007/s10156-013-0567-z
  17. Sridharan P, Chamberlain R.S. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? Surg Infect (Larchmt). 2013;14(6):489-511. doi: 10.1089/sur.2012.028
  18. Kellum J.A, Kong L, Fink M.P, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):1655-63.
  19. Bronkhorst M.W, Patka P, Van Lieshout E.M. Effects of Sequence Variations in Innate Immune Response Genes on Infectious Outcome in Trauma Patients: A Comprehensive Review. Shock. 2015;44(5):390-6. doi: 10.1097/SHK.0000000000000450
  20. Mera S, Tatulescu D, Cismaru C, et al. Multiplex cytokine profiling in patients with sepsis. APMIS. 2011;119(2):155-63. doi: 10.1111/j.1600-0463.2010.02705.x
  21. Chaudhry H, Zhou J, Zhong Y, et al. Role of cytokines as a double - edged sword in sepsis. In Vivo. 2013;27(6):669-84.
  22. Luzina I.G, Lockatell V, Todd N.W, et al. Splice isoforms of human interleukin-4 are functionally active in mice in vivo. Immunology. 2011;132(3):385-93. doi: 10.1111/j.1365-2567.2010.03393.x
  23. Долгушин И.И., Торопова Л.Р., Савочкина А.Ю. и др. Динамика изменения показателей функциональной активности нейтрофилов у больных сепсисом с неблагоприятным исходом. Российский иммунологический журнал. 2017;11(2):295-6.
  24. Power C, Wang J.H, Sookhai S. Proinflammatory effects of bacterial lipoprotein on human neutrophil activation status, function and cytotoxic potential in vitro. Shock. 2001;15(6):461-6.
  25. Yaroustovsky M, Rogalskaya E, Plyushch M, Klimovich L, Samsonova N, Abramyan M. The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis. Int J Inflam. 2017;2017:3495293. doi: 10.1155/2017/3495293

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies